| Financial Year |
March 31 2023 |
| Monetary Funds |
748,995,644.52 |
| Held-for-trading Financial Assets |
1,283,682,046.63 |
| Notes Receivable |
2,017,395.00 |
| Accounts Receivable |
564,452,271.95 |
| Advances to Suppliers |
39,547,066.94 |
| Other Receivables |
86,122,261.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
466,705,476.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,361,256.89 |
| Total Current Assets |
3,214,883,420.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
362,740,750.98 |
| Investment Properties |
-- |
| Fixed Assetes |
970,493,218.89 |
| Under-construction Projects |
270,525,935.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
201,257,838.63 |
| R&D expenses |
49,977,100.62 |
| Goodwill |
115,371,168.89 |
| Long-Term Deferred and Prepaid Expenses |
12,005,117.84 |
| Deferred Income Tax Assets |
57,589,273.07 |
| Other Non-Current Assets |
28,835,035.50 |
| Sub-Total of Non-Current Assets |
2,702,872,379.89 |
| Total Assets |
5,917,755,800.57 |
| Short-Term Loans |
3,000,000.00 |
| Trading Financial liabilities |
15,638,100.00 |
| Notes Payable |
-- |
| Accounts Payable |
215,376,014.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
73,366,252.27 |
| Taxes Payable |
68,391,283.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
57,516,119.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,573,584.06 |
| Other Current Liabilities |
1,360,812.88 |
| Sub-Total of Current Liabilities |
519,673,677.03 |
| Long-term Loans |
-- |
| Bonds Payable |
539,027,522.55 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
54,470,295.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
651,624,436.65 |
| Total Liabilities |
1,171,298,113.68 |
| Paid-In Capital(Or Share Stock) |
444,514,860.00 |
| Capital Surplus |
781,822,585.31 |
| Surplus Reserve |
261,061,579.09 |
| LESS:Treasury Stock |
157,297,580.75 |
| Undistributed Profits |
3,108,234,993.40 |
| Minority Stockholder's Interest |
192,336,909.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,554,120,777.67 |
| Owner's Equity（Stockholder's Equity） |
4,746,457,686.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,917,755,800.57 |
